Sinovac Biotech Ltd.

SVA·NASDAQ·$6.47·$465M

Financials

20-FAnnual report (foreign)06/05/2620-FAnnual report (foreign)04/30/2620-FAnnual report (foreign)04/29/2420-FAnnual report (foreign)05/01/2320-FAnnual report (foreign)04/29/22

Disclosures

6-KForeign issuer report08/17/266-KForeign issuer report07/15/266-KForeign issuer report06/15/266-KForeign issuer report06/05/266-KForeign issuer report05/29/26

Prospectuses and Registrations

S-8Registration of securities for employees09/04/13424B5Prospectus supplement01/28/10F-3MEFProspectus / registration01/27/10424B5Prospectus supplement01/20/10424B3Prospectus12/02/09

Proxies

PRE 14APreliminary proxy01/12/06

Ownership

Form 3Initial insider ownership04/17/26Form 3Initial insider ownership03/18/26Form 3Initial insider ownership03/18/26Form 3Initial insider ownership03/18/26Form 3Initial insider ownership03/18/26

Other

NT 20-FLate filing notification (20-F)04/30/26NT 20-FLate filing notification (20-F)04/29/25SC TO-T/ASC TO-T/A03/18/248-A12B/A8-A12B/A02/21/24SC TO-T/ASC TO-T/A02/02/24